Why BGPT?
logo

Author Review — Track Authors' Data

Inspect an author's raw data, methods, and reproducibility across their publications.

Press Enter ↵ to find



    Explore by Goal




     Quick Explanation



    Michael B. Schultz — evidence available here is insufficient for a rigorous author-strength assessment.
    I only see (a) an OpenAlex snippet that appears to conflate multiple “Michael Schultz” identities (no clear mapping to “Michael B. Schultz”), and (b) one extracted paper with DOI 10.1016/S0016-5085(14)60274-2 that is not explicitly shown to include Michael B. Schultz in the provided text. Given BGPT’s “no assumptions” constraint, I cannot responsibly score author-specific scientific quality beyond flagging the evidence gaps.



     Long Explanation



    Author Review (Critical, Evidence-Gated): “Michael B. Schultz”
    Key constraint: Your prompt requests accurate, evidence-based claims with inline citations. However, the provided material does not clearly identify which publications belong to Michael B. Schultz (the OpenAlex snippet contains multiple similarly named authors) and only one DOI-linked paper excerpt is supplied, without explicit author attribution to “Michael B. Schultz”.
    Visual: The only DOI-linked extracted paper you provided
    Paper (from your dataset): “333 International Multicentre Study of Optimal Use of the Glasgow Blatchford Score in Identifying Low-Risk Patients With Upper Gastrointestinal Bleeding Suitable for out-Patient Management” (paper_date: May 01, 2014). DOI: 10.1016/S0016-5085(14)60274-2 (Author mapping to “Michael B. Schultz” is not shown in the provided excerpt.)
    What can be concluded about scientific strength (from the evidence provided)
    1) Identity resolution problem (major blocker). Your OpenAlex snippet lists multiple different authors with similar names (e.g., several entries for “Michael Schultz” / “Michael B. Schultz”), and does not explicitly show that those metrics correspond to the exact string “Michael B. Schultz”. Because of this, any author-level scoring would be a guess, which you explicitly disallow.
    2) Publication-level evidence is incomplete. Only one DOI is clearly provided in your “research data to utilize,” and the excerpt includes no explicit author attribution to “Michael B. Schultz”. Without confirmed authorship, the extracted study’s quality scores cannot be confidently used to evaluate the target author.
    3) Still, we can scrutinize the single provided DOI-linked study excerpt (as a proxy for topic rigor, not authorship). The excerpt describes a large multicenter study evaluating performance of Glasgow Blatchford Score thresholds and modifications in upper GI bleeding triage, using diagnostic performance concepts (sensitivity/specificity) to classify “low-risk” patients and estimating potential admission reduction; it also flags site variability and potential generalizability limitations beyond Europe.
    Evidence snippet (from the provided excerpt) — cited study
    The excerpt reports a sample of 2305 patients across multiple centers and suggests that using a GBS cut-off of ≤1 (and age-extended versions) identifies about twice as many low-risk patients as a cut-off of zero, while flagging variability across sites and possible generalizability limits.
    Bottom line: With the current evidence constraints, the scientific strength of “Michael B. Schultz” cannot be robustly assessed. The most scientifically honest output is: insufficient attribution + insufficient publication set.
    Common failure modes (skeptical audit)
    • Author-name conflation: multiple distinct researchers can share similar names; scoring must be tied to verified works.
    • Attribution missingness: if we don’t know whether the target author contributed to the cited DOI, we can’t use it for author-quality scoring.
    • Over-reliance on citations: high citation counts can reflect field size, practice-changing papers, or visibility; they don’t guarantee methodological rigor for every contribution.
    • Publication bias & selective reporting: without full text and full study set, it’s easy to overcount favorable outcomes.
    What I need from you (to make this a real author-strength review)
    Provide at least one of the following:
    • Michael B. Schultz’s ORCID or verified institutional identity, or
    • a list of the author’s DOI(s)/paper titles you want evaluated, or
    • confirm which OpenAlex ID corresponds to the target author (e.g., an OpenAlex A-ID that you confirm is “Michael B. Schultz”).


    Feedback:   

    Updated: May 01, 2026

    BGPT Author Review



    Scientific Quality

    20%

    I cannot evaluate “Michael B. Schultz” scientifically from the provided evidence because (1) the supplied OpenAlex snippet likely conflates multiple similarly named authors and (2) only one DOI-linked paper excerpt is provided without confirmed authorship by the target individual. Any higher score would require unverifiable assumptions.



    Communication Quality

    30%

    No actual writing, abstract, or argumentation by “Michael B. Schultz” was provided—only metadata/excerpts—so communication quality cannot be meaningfully assessed.



    Author Novelty

    20%

    Novelty cannot be assessed because the author’s confirmed publication set is missing; the single provided excerpt is topic-relevant but not author-attributed in the prompt.



    Scientific Rigor

    30%

    The excerpted GBS multicenter study is described as using standard diagnostic-performance concepts and includes stated limitations (e.g., site variability), but because the author’s participation is not confirmed, I cannot credit rigor to Michael B. Schultz specifically.

     Analysis Wizard



    No bioinformatics computation is justified from the provided evidence; the correct next step is author-identity disambiguation and extraction of the author’s verified DOI set before any scoring.



     Hypothesis Graveyard



    “High citation counts imply high rigor” is a weak strongman claim here because citations are confounded by visibility, field size, and authorship disambiguation errors.


    “One good paper proves the author is rigorous” is untenable because the paper’s authorship to the target individual is not verified in the provided excerpt.

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Follow the Evidence

    New scientific claims, supporting evidence, and important limitations. Every Friday. No ads.


    My BGPT